Diabetes Research
Diabetes is a growing epidemic in our country. According to the CDC, 38.4 million people – 11.6% of the U.S. population – have diabetes. Additionally, 97.6 million people – 38% of the adult U.S. population – have prediabetes. Diabetes and prediabetes increase the risk of heart disease, stroke, blindness, amputations and kidney failure. APhA Foundation is committed to improving the care of people through its highly successful diabetes initiatives.
Diabetes Initiatives
Diabetes is one of the greatest challenges facing our healthcare system. Our diabetes initiatives have shown reduced healthcare costs, improved clinical outcomes, and shaped pharmacists’ role in diabetes care. Whether you are a pharmacist looking to collaborate on a diabetes project, a physician looking to refer your patients, or an individual looking to participate in a diabetes prevention program, we have a solution.
1
Project IMPACT: Diabetes transformed health care delivery in local communities and improved patient outcomes. Through the proven collaborative care model developed and used by the APhA Foundation for nearly two decades, patients became better informed and learned how to self-manage their condition.
2
Project IMPACT Diabetes Prevention enables care teams to deliver personalized, collaborative care to patients at risk of developing type 2 diabetes.
Learn more about our Team Based Care approach and opportunities to collaborate with APhA Foundation.
.
3
More than 96 million American adults have prediabetes
More than 80% of individuals with prediabetes do not know they have it
70% of at-risk individuals will eventually develop type 2 diabetes without intervention
Learn more about diabetes prevention and see if enrolling in a lifestyle change program is right for you.
OUR NATIONWIDE, INTERDISCIPLINARY COMMUNITY
Community pharmacies, physicians, health centers, self-insured employers and many other organizations have joined IMPACT Diabetes to help thousands of patients across the nation take control of their health to prevent type 2 diabetes.
Physicians
collaborate with the entire healthcare team for improved patient outcomes
Pharmacists
lead the collaboration among patients, providers, and family members for increased engagement and retention
Care Teams
are seamlessly engaged to ensure continuity of care and lasting impact
Learn more about our diabetes research through the years
PATIENT SELF-MANAGEMENT PROGRAM FOR DIABETES
Patient Self-Management Program for Diabetes, supported by Aventis Pharmaceuticals, was the APhA Foundation’s first diabetes demonstration project. Over a one-year patient care period, self-insured employers in 5 geographic areas observed significantly improved clinical indicators of diabetes management, higher rates of self-management goal setting and achievement for beneficiaries, increased satisfaction with diabetes care, and decreased total medical costs.
OVERCOMING THERAPEUTIC INERTIA
Through collaboration with the American Diabetes Association (ADA) the APhA Foundation highlights the work of exceptional pharmacists in various practice settings as they give insight on Overcoming Therapeutic Inertia as it relates to the provision of diabetes-related, pharmacist-provided care.
DIABETES TEN CITY CHALLENGE
Diabetes Ten City Challenge (DTCC), conducted by the APhA Foundation with support from GlaxoSmithKline, demonstrated that self-insured employers can improve recognized standards of diabetes care and reduce health care expenditures when they offer employees, dependents and retirees the opportunity to meet with specially-trained pharmacist “coaches” to help manage their diabetes.
THE ASHEVILLE PROJECT
The Asheville Project began in 1996 as an effort by the City of Asheville, North Carolina, a self-insured employer, to provide education and personal oversight for employees with chronic health problems such as diabetes, asthma, hypertension and high cholesterol. The highly successful model from the project has been expanded upon extensively through the APhA Foundation's research.